| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Biochemistry, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark, New Jersey 07103
2 To whom requests for reprints should be addressed.
In order to elucidate the enzymic basis of nitrosamine metabolism, the in vitro metabolism of nitrosamines by rat liver microsomes and the effects of fasting on the microsomal enzymes have been studied. Fasting for 1 to 3 days causes a 2- to 3-fold enhancement of the reduced nicotinamide adenine dinucleotide phosphate-dependent nitrosodimethylamine demethylase (NDMAD) activity. The cytochrome P-450 content and the activities of reduced nicotinamide adenine dinucleotide phosphate-cytochrome P-450 reductase and benzphetamine demethylase, however, are only modestly increased. Gel electrophoretic analysis reveals the induction of a 50,000-dalton protein band during fasting. The induction of this protein band as well as the enhancement of NDMAD activity are inhibited by CoCI2 and inhibitors of protein and RNA biosynthesis. The involvement of cytochrome P-450 in the NDMAD is supported by the fact that microsomal reduced nicotinamide adenine dinucleotide phosphate-cytochrome P-450 reductase is required for the demethylase activity. Kinetic analysis indicates that a low-Km form of NDMAD (apparent Km, 0.07 mM) is markedly induced by fasting. With microsomes of control rats, there are at least three apparent Km values (0.07, 0.38, and 38.6 mM) for NDMAD; but with microsomes of fasting rats, the low-Km (0.07 mM) form is predominant. These results suggest that rat liver microsomes contain a cytochrome P-450 isozyme which has high affinity for nitrosodimethylamine, and this isozyme is induced by fasting. In addition to nitrosodimethylamine, the oxidative demethylation of N-nitroso-N-methylethylamine, N-nitroso-N-methylbutylamine, N-nitroso-N-methylaniline, and N-nitroso-N-methylbenzylamine is also enhanced by fasting. The extent of enhancement and substrate dependency of these reactions, however, is different from that of NDMAD.
1 This work was supported by Grant CA 16788 from the National Cancer Institute and a grant from Hoffmann-La Roche Inc.
Received 3/28/82. Accepted 10/21/82.
This article has been cited by other articles:
![]() |
J. L. Raucy, J. Lasker, K. Ozaki, and V. Zoleta Regulation of CYP2E1 by Ethanol and Palmitic Acid and CYP4A11 by Clofibrate in Primary Cultures of Human Hepatocytes Toxicol. Sci., June 1, 2004; 79(2): 233 - 241. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. S. Sohn, E. S. Fiala, S. P. Requeijo, J. H. Weisburger, and F. J. Gonzalez Differential Effects of CYP2E1 Status on the Metabolic Activation of the Colon Carcinogens Azoxymethane and Methylazoxymethanol Cancer Res., December 1, 2001; 61(23): 8435 - 8440. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Frei, F. Gilberg, M. Schroder, A. Breuer, L. Edler, and M. Wiessler Analysis of the inhibition of N-nitroso-dimethylamine activation in the liver by N-nitro-dimethylamine using a new non-linear statistical method Carcinogenesis, March 1, 1999; 20(3): 459 - 464. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Amato, V. Longo, A. Mazzaccaro, and P. G. Gervasi Chlorzoxazone 6-Hydroxylase and p-Nitrophenol Hydroxylase as the Most Suitable Activities for Assaying Cytochrome P450 2E1 in Cynomolgus Monkey Liver Drug Metab. Dispos., May 1, 1998; 26(5): 483 - 489. [Abstract] [Full Text] |
||||
![]() |
S. P. Carpenter, D. D. Savage, E. D. Schultz, and J. L. Raucy Ethanol-Mediated Transplacental Induction of CYP2E1 in Fetal Rat Liver J. Pharmacol. Exp. Ther., August 1, 1997; 282(2): 1028 - 1036. [Abstract] [Full Text] |
||||
![]() |
R. W. Wang, D. J. Newton, T. D. Scheri, and A. Y. H. Lu Human Cytochrome P450 3A4-Catalyzed Testosterone 6beta -Hydroxylation and Erythromycin N-Demethylation. Competition During Catalysis Drug Metab. Dispos., April 1, 1997; 25(4): 502 - 507. [Abstract] [Full Text] |
||||
![]() |
M. BLACK and J. RAUCY Acetaminophen, Alcohol, and Cytochrome P-450 Ann Intern Med, March 1, 1986; 104(3): 427 - 429. [Abstract] [PDF] |
||||
![]() |
M.-A. Robin, H. K. Anandatheerthavarada, J.-K. Fang, M. Cudic, L. Otvos, and N. G. Avadhani Mitochondrial Targeted Cytochrome P450 2E1 (P450 MT5) Contains an Intact N Terminus and Requires Mitochondrial Specific Electron Transfer Proteins for Activity J. Biol. Chem., June 29, 2001; 276(27): 24680 - 24689. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |